期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 108 (2)
Objectives and Methods Intracranial hemorrhage (ICH) in acute myeloid leukemia (AML) patients is a major concern due to the increased risk of mortalit......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (2)
Objective Acute graft-versus-host disease (aGVHD) is a major cause of treatment-related mortality after allogeneic hematopoietic stem cell transplanta......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (2)
COVID-19 is a potential life-threatening viral disease caused by SARS-CoV-2 and was declared a pandemic by the WHO in March 2020. mRNA-based SARS-CoV-......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (3)
Objectives Evidence about the cross-talk between iron, glucose metabolism, and cardiac disease is increasing. We aimed to explore the link of pancreat......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (6)
Objective Dual-energy X-ray absorptiometry (DXA) remains the cornerstone for osteoporosis evaluation in Thalassemia major. However, several drawbacks ......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (6)
Background Autoimmune conditions in B-cell lymphomas are frequent. Steroids are standard of care, but many patients require other immunosuppressive ag......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (1)
Objectives: Our aim was to correlate serum levels of selected markers of bone metabolism and bone marrow microenvironment to cytogenetic changes in pa......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (3)
Background The effects of eculizumab treatment in paroxysmal nocturnal hemoglobinuria (PNH) patients with or without high-disease activity (HDA), defi......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (1)
Objectives Both peripherally inserted central catheters (PICCs) and implanted port catheters (PORTs) are commonly used for the delivery of immunochemo......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (2)
Objectives Polatuzumab vedotin with bendamustine and rituximab (Pola-BR) was approved for treatment of transplant-ineligible patients with relapsed/re......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (3)
High-dose chemotherapy followed by autologous stem cell transplantation (auto-SCT) is the standard treatment for young patient <= 65 years with mul......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (6)
Objectives Despite the effectiveness of newer drugs for the treatment of multiple myeloma (MM), the outcomes are further improved by subsequent autolo......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 108 (1)
Objective We investigated the efficacy and safety of carfilzomib-containing induction before salvage high-dose melphalan with autologous stem-cell tra......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 108 (3)
Introduction Accumulating studies show that the tumour suppressor SOCS1 is one of the most frequently mutated genes in lymphomas, often affecting the ......
期刊： EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 108 (4)
Background Intracranial hemorrhage is seen more frequently in acute leukemia patients compared to the general population. Besides leukemia-related ris......
